CATALYST PHARMACEUTICALS INC. - COMMON STOCK

Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022

25 апр 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

16 мар 2022 16:20:58 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®

11 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies

08 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 16, 2022

03 мар 2022 09:20:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio

02 мар 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022

24 фев 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022

17 фев 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2021 Total Revenues; Provides 2022 Total Revenue Guidance and Corporate Update

07 фев 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports that the FDA Marketing Approval Previously Granted for Ruzurgi® is No Longer Valid

03 фев 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. Court of Appeals for the 11th Circuit Directing the District Court Judge in Catalyst's Lawsuit Against the FDA to Grant Summary Judgement in Favor of Catalyst

28 янв 2022 13:46:42 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Company Inc.'s Petition for Rehearing

10 янв 2022 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences

04 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a Phase 3 Study for FIRDAPSE® (amifampridine) in Japan

06 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

15 ноя 2021 16:15:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results

09 ноя 2021 16:15:04 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021

25 окт 2021 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exclusivity for Firdapse® for LEMS

30 сен 2021 12:08:12 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

17 сен 2021 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

10 сен 2021 08:03:00 Источник Nasdaq GlobeNewswire